Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The dynamics of the Hydronephrosis market are highly driven by medical, technical and demographic factors that affect diagnostic and therapeutic demand. Kidney swelling due to urine retention is a condition referred to as hydronephrosis, which can be caused by kidney stones, UTIs or congenital defects. The market is driven by better diagnosis and treatment technologies whose occurrence is rising with an increase in cases of hydronephrosis.
Hydronephrosis market is fueled by diagnostic innovations. Since they must rely on accurate results from these tests, which are also effective in managing the condition, there has been a high demand for such diagnostic technologies. Demographic factors such as older populations and increased incidence of kidney stones and urinary tract infections affect the Hydronephrosis market. Aging increases risk of developing hydronephrosis. Market adjustments will result in a wide variety of diagnostic procedures for hydronephrosisis required within a diverse and aging population.
Hydronephrosismarket rivals consist of manufacturersof medical devices,and healthcare providers offering diagnostics as well as therapeutics. These companies develop innovative technologies that improve accuracy in diagnosing the disorder while minimizing invasiveness through treatment options.The competition involves product efficacy, technological advancement,and holistic approaches towards management of this ailment.
Government regulations along with healthcare infrastructure drive Hydronephrosismarket dynamics.Governments globally have taken up measures toward prevention, early detectionand managementof kidney related diseases.Regulatory frameworks for approvaland adoptionare needed in orderfor diagnostic or therapeutictechnologies to be marketed.Awareness campaigns plus educational initiatives encourage early identification of hydronephrosissigns and symptoms.
The Hydronephrosis industry, despite advancements in diagnosis and treatment, still faces challenges. Inability to access healthcare due to disparity especially in low-income regions may result in delays for both diagnostic check-up or treatment.A few population segments might not afford expensive diagnostics as well as therapies. Tackling these issues will therefore require merging public health, healthcare infrastructure and awareness with accessibility.
Hydronephrosis Market Highlights:
Hydronephrosis Market Overview
Hydronephrosis Market Size was valued at USD 3.22 Billion in 2023. The Global Hydronephrosis industry is projected to grow from USD 3.57 Billion in 2024 to USD 8.16 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 11.20% during the forecast period (2024 - 2032).
Hydronephrosis is a condition characterized by a swollen kidney as a result of abnormal drainage of urine from the kidney to the bladder. It is a secondary disease that results from primary disease that may affect the kidney. Symptoms of hydronephrosis includes fever, pain when urinating, nausea or vomiting, and pain in the abdomen. It may be unilateral or bilateral. Unilateral hydronephrosis is swelling of one kidney, whereas, bilateral hydronephrosis is swelling of both the kidneys. Hydronephrosis is mostly diagnosed through ultrasound examination.
Hydronephrosis has become a major problem across the globe due to rising prevalence of kidney diseases, lack of awareness about the diseases and their treatment, which favor the growth of the market. Rising prevalence of kidney diseases especially, in the geriatric population and availability of cost-effective treatment propel the market growth.
Hydronephrosis Market Segment Insights
The hydronephrosis market is segmented on the basis of types, which includes unilateral hydronephrosis and bilateral hydronephrosis.
Hydronephrosis Diagnosis Insights
On the basis of diagnosis, the hydronephrosis market is segmented into laboratory test and imaging. Laboratory test is further segmented into urinalysis, Complete Blood Count (CBC), electrolyte analysis, and others. Imaging is further sub-segmented into CT scan, ultrasound, intravenous pyelography, KUB X-rays, and others.
Hydronephrosis Treatment Insights
On the basis of treatment, the hydronephrosis market is segmented into shock wave lithotripsy, laparoscopy, bladder catheterization, steroid therapy, and others.
Hydronephrosis Indication Insights
On the basis of indication the hydronephrosis market is segmented into intrinsic and extrinsic causes of hydronephrosis. The intrinsic causes are further sub-segmented into acute unilateral obstructive uropathy, kidney stone, bladder cancer, bladder stones, cystocele, urethral stricture, urethral cancer and others. The extrinsic causes are further sub-segmented into retroperitoneal fibrosis, ovarian vein syndrome, cancer of the cervix, cancer of the prostate, uterine prolapse, prostate cancer, and others.
Hydronephrosis Regional Insights
The American region accounted for the largest share of the global market due to increasing prevalence of chronic kidney diseases, and rising demand for diagnosis and treatment of hydronephrosis. Hydronephrosis are leading urological diseases in the U.S. According to the Center for Diseases Control and Prevention, 48,146 deaths occurred due to nephrosis and kidney diseases in the year 2014. It also stated that the number of adults diagnosed with kidney diseases in 2014 was 4.9 million in the US.
Europe is the second largest market that holds a noticeable share of the hydronephrosis market. According to the European database for surveillance of congenital malformations report, hydronephrosis is prevalence among new born and pregnant women.
In Asia Pacific, rising prevalence of kidney stone, rising geriatric population and growing demand for counselling about hydronephrosis drive the market growth.
The Middle East & Africa is expected to show a steady growth in this market due constant demand for diagnostics devices, awareness about maternal and child health in most of the African countries and the government efforts to cater primary health need of the population.The report on the hydronephrosis market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain deeper insight to the market and industry performance. The hydronephrosis market report gives a clear picture of the current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regions.
Key Players in the Hydronephrosis Market
Some of the key players in hydronephrosis market are
- NephroGenex, Inc. (U.S)
- American Renal Associates (U.S)
- PHRAXIS, INC. (U.S)
- Renal Associates P.A. (U.S)
- ALLERGAN (U.S)
- Amgen Inc. (U.S)
- Anthem Bio Pharm (U.S)
- Sanofi (U.S)
- Novartis AG (Germany)
Intended Audience
- Medical Device Manufacturers
- Medical Device Suppliers
- Medical Research Laboratories
- Research and Development (R&D) Companies
- Market Research and Consulting Service Providers
- Potential Investors
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
